# Assessing Response to Neoadjuvant Chemotherapy With HD PET/CT, Serum Glycomic Markers and Tissue Muc-1 Isoforms

> **NCT01110174** · NA · COMPLETED · sponsor: **University of California, Davis** · enrollment: 8 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** HD PET/CT

## Key facts

- **NCT ID:** NCT01110174
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01110174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01110174, "Assessing Response to Neoadjuvant Chemotherapy With HD PET/CT, Serum Glycomic Markers and Tissue Muc-1 Isoforms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01110174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*